{"database": "lobbying", "table": "lobbying_activities", "rows": [[1299014, "d15869e2-bfcd-4dfa-8a89-eab28aa0fa78", "Q3", "DENNY MILLER ASSOCIATES", 25328, "CELL THERAPEUTICS", 2012, "third_quarter", "PHA", "European Union approval of US cancer drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2012-10-15T13:55:42.557000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1299014"], "units": {}, "query_ms": 0.413742964155972, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}